Learn More
Medchemexpress LLC ML-7 hydrochloride | 110448-33-4 | C15H18ClIN2O2S | 25 MG

Supplier: Medchemexpress LLC 25MGHY15417
ML-7 hydrochloride is a naphthalene sulphonamide derivative that potently inhibits Myosin Light Chain Kinase (MLCK) with an IC₅₀ of 300 nM, and also inhibits YAP/TAZ. This product is intended for research use only.
- Potently inhibits Myosin Light Chain Kinase (MLCK) with an IC₅₀ of 300 nM.
- Inhibits YAP/TAZ.
- Inhibits rabbit portal vein α1-adrenoceptor NSCC with an IC₅₀ of 0.8 μM.
- Attenuates Dexmedetomidine (DMT)-induced contraction.
- Reduces intracerebral Evans Blue extravasation, suggesting a reduction in brain edema.
- Reduces brain water content and improves neurological function after controlled cortical impact (CCI).
- Significantly reduces the protein level of phosphorylated MLC2 and the phosphorylation ratio of MLC2 in BMECs.
- Directly inhibits the expression of ZO-1.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.